tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

DNLI Stock Latest News

Denali Therapeutics price target lowered to $42 from $50 at Oppenheimer
The FlyDenali Therapeutics price target lowered to $42 from $50 at Oppenheimer
2h ago
DNLI
Denali Therapeutics: Promising Drug Pipeline and Financial Stability Support Buy Rating
PremiumRatings
Denali Therapeutics: Promising Drug Pipeline and Financial Stability Support Buy Rating
4h ago
DNLI
Denali Therapeutics price target lowered to $32 from $33 at Wedbush
PremiumThe Fly
Denali Therapeutics price target lowered to $32 from $33 at Wedbush
3d ago
DNLI
Positive Outlook for Denali Therapeutics: Strategic Progress and Promising Developments Support Buy Rating
PremiumRatings
Positive Outlook for Denali Therapeutics: Strategic Progress and Promising Developments Support Buy Rating
3d ago
DNLI
Denali Therapeutics: Promising ETV Platform and Strategic Advancements Justify Buy Rating
PremiumRatings
Denali Therapeutics: Promising ETV Platform and Strategic Advancements Justify Buy Rating
3d ago
DNLI
Denali Therapeutics price target lowered to $80 from $87 at H.C. Wainwright
PremiumThe FlyDenali Therapeutics price target lowered to $80 from $87 at H.C. Wainwright
3d ago
DNLI
Denali Therapeutics Reports 2024 Financial Results and Progress
Premium
Company Announcements
Denali Therapeutics Reports 2024 Financial Results and Progress
3d ago
DNLI
Denali Therapeutics Signs New Equity Distribution Deal
Premium
Company Announcements
Denali Therapeutics Signs New Equity Distribution Deal
4d ago
8K
DNLI
Denali Therapeutics reports Q4 EPS (67c), consensus (85c)
PremiumThe Fly
Denali Therapeutics reports Q4 EPS (67c), consensus (85c)
4d ago
DNLI
Denali Therapeutics files automatic mixed securities shelf
PremiumThe Fly
Denali Therapeutics files automatic mixed securities shelf
4d ago
DNLI
Denali Therapeutics initiated with a Buy at Deutsche Bank
PremiumThe Fly
Denali Therapeutics initiated with a Buy at Deutsche Bank
20d ago
DNLI
Denali Therapeutics announces primary analysis of Phase 1/2 study in MPS II
PremiumThe Fly
Denali Therapeutics announces primary analysis of Phase 1/2 study in MPS II
25d ago
DNLI
Denali Therapeutics Outlines 2025 Milestones and Strategies
PremiumCompany AnnouncementsDenali Therapeutics Outlines 2025 Milestones and Strategies
2M ago
8K
DNLI
Denali Therapeutics announces U.S. FDA BTD granted for tividenofusp
Premium
The Fly
Denali Therapeutics announces U.S. FDA BTD granted for tividenofusp
2M ago
DNLI
Denali recent pullback a buying opportunity, says Jefferies
Premium
The Fly
Denali recent pullback a buying opportunity, says Jefferies
2M ago
DNLI
BofA trims Denali Therapeutics price target to $30, says weakness an opportunity
PremiumThe Fly
BofA trims Denali Therapeutics price target to $30, says weakness an opportunity
2M ago
DNLI
Denali Therapeutics price target lowered to $32 from $35 at BTIG
PremiumThe Fly
Denali Therapeutics price target lowered to $32 from $35 at BTIG
2M ago
DNLI
3 Best Stocks to Buy Now, 1/7/2025, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 1/7/2025, According to Top Analysts 
2M ago
HG
UAL
Denali Therapeutics price target lowered to $87 from $90 at H.C. Wainwright
PremiumThe Fly
Denali Therapeutics price target lowered to $87 from $90 at H.C. Wainwright
2M ago
DNLI
Denali Therapeutics’ ALS Drug Fails Phase 2/3 Trial
PremiumCompany AnnouncementsDenali Therapeutics’ ALS Drug Fails Phase 2/3 Trial
2M ago
8K
DNLI
Denali Therapeutics initiated with an Outperform at Baird
Premium
The Fly
Denali Therapeutics initiated with an Outperform at Baird
2M ago
DNLI
Closing Bell Movers: Inari adds 21% after confirmed Stryker buyout
Premium
The Fly
Closing Bell Movers: Inari adds 21% after confirmed Stryker buyout
2M ago
SYK
ADCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >